Los Alamos National Laboratory
Lab Home  |  Phone

Technology Transfer, TT

Material Transfer Agreement (MTA)

Materials are typically the starting point, or at least play a crucial role in creating new innovations. As a result, the use of materials is potentially very valuable for generating novel intellectual property.

The MTA defines the intellectual property rights of the provider and the recipient with respect to the materials and any derivatives. Biological materials, such as reagents, cell lines, plasmids, and vectors, are the most frequently transferred materials. However, MTAs may also be used for other types of materials, such as chemical compounds and even some types of software.

Below are customized MTAs for our most frequently requested materials organized by Principal Investigator (PI).


Download the appropriate MTA. Complete the MTA in its entirety. Any missing information could result in delayed processing. 

For foreign entities, be sure to complete both Appendix A and Appendix B of the MTA.

Once you have obtained the appropriate signature, either fax copy of the MTA to 1-505-665-0154 (Attn: MTA Processing) or email a scanned copy of the MTA to mta@lanl.gov.

Available Materials (by PI)

Andrew Bradbury, Ph.D.

Plasmids for phage display as described in Nucleic Acids Research, 2006, 34(21), e145

Antibody that recognizes sulfation as a post-translational modification

Display Plasmids as described in Nucleic Acids Res 38, e22, (2010)

Anti-M2 antibody as described inProtein Eng Des Sel 22, 189-198, (2009)

Cre cells as described in Gene 70, 331-341 (1988)

 scFv plasmids

The original library and derived antibodies are owned by Merrimack Pharmaceuticals, and for any commercial use of these plasmids/ antibodies a commercial license must be obtained from Merrimack.

Thermostable fluorescent proteins described in Protein Eng Des Sel 22, 313-323, (2009)



Green Fluorescent Protein (GFP) Materials

LANL has teamed up with a local biotechnology company to distribute many of the GFP components. As of November 15, 2008, non-commercial entities interested in obtaining LANL's in vitro Split GFP, Superfolder GFP, or a mammalian codon-optimized version of the in vivo Split GFP plasmids need to obtain the materials through our partner, Sandia Biotech, Inc. All commercial parties interested in licensing these materials should visit LANL's GFP licensing page.

Geoffrey Waldo, Ph.D.

 Folding Reporter

 Superfolder GFP

 Insertion GFP

 Split GFP in vitro

 Split GFP in vivo

 Mammalian codon-optimized Split GFP in vivo



Back to Partnering

Operated by Los Alamos National Security, LLC for the U.S. Department of Energy's NNSA

Inside | © Copyright 2010-11 Los Alamos National Security, LLC All rights reserved | Disclaimer/Privacy | techtransfer@lanl.gov